Literature DB >> 10854432

Alternatively spliced isoforms of TFII-I. Complex formation, nuclear translocation, and differential gene regulation.

V Cheriyath1, A L Roy.   

Abstract

TFII-I is a multifunctional phosphoprotein with roles in transcription and signal transduction. Here we report characterization of three additional alternatively spliced isoforms of TFII-I. Employing isoform-specific antibodies, we show that the isoforms form a stable complex in vivo preferentially in the nucleus compared with the cytoplasm. We further show that both homomeric and heteromeric interactions are possible and that the heteromeric interactions between a wild type and a nuclear localization-deficient mutant result in nuclear translocation of the complex, leading us to postulate that complex formation might aid in nuclear translocation. In functional assays all four isoforms individually bind to DNA and transactivate reporter genes to a similar extent. However, although co-expression of different TFII-I isoforms leads to enhanced basal activity, it results in attenuated signal responsive activity. Thus, TFII-I might differentially regulate its target genes via complex or subcomplex formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854432     DOI: 10.1074/jbc.M002980200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

2.  Inhibition of TFII-I-dependent cell cycle regulation by p53.

Authors:  Zana P Desgranges; Jinwoo Ahn; Maria B Lazebnik; Todd Ashworth; Caleb Lee; Richard C Pestell; Naomi Rosenberg; Carol Prives; Ananda L Roy
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  Repression of TFII-I-dependent transcription by nuclear exclusion.

Authors:  M I Tussié-Luna; D Bayarsaihan; F H Ruddle; A L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Signal-induced functions of the transcription factor TFII-I.

Authors:  Ananda L Roy
Journal:  Biochim Biophys Acta       Date:  2007-10-11

5.  Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Authors:  Jaya Rajaiya; Jamee C Nixon; Neil Ayers; Zana P Desgranges; Ananda L Roy; Carol F Webb
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 6.  The contribution of GTF2I haploinsufficiency to Williams syndrome.

Authors:  Thanathom Chailangkarn; Chalongrat Noree; Alysson R Muotri
Journal:  Mol Cell Probes       Date:  2018-01-03       Impact factor: 2.365

7.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

8.  Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

Authors:  Timothy A Hinsley; Pamela Cunliffe; Hannah J Tipney; Andrew Brass; May Tassabehji
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

9.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

10.  Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.

Authors:  Enoch S E Tay; Kim L Guven; Nanthakumar Subramaniam; Patsie Polly; Laura L Issa; Peter W Gunning; Edna C Hardeman
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.